Merck KGaA MKGAF
170.10 USD +2.98 (+1.78%)
At closeNov 9, 2026, 4:00 PM EST
169.70 Day range 169.70
116.68 52-week range 175.56
- YTD
- +15.24%
- 1 year
- +32.74%
- Market cap
- 73.96B
- EPS (ttm)
- 6.25
- P/E ratio
- 27.22
- YTD return
- +15.24%
- 1-year return
- +32.74%
- Volume
- 97
- Avg volume
- 637
- Open
- 169.70
- Previous close
- 167.12
- Day's range
- 169.70 – 169.70
- 52-week range
- 116.68 – 175.56
- Earnings date
- Nov 12, 2026
No chart data for this range yet.
Next earnings
Nov 12, 2026
Expected Nov 12, 2026. Consensus EPS estimate 2.35.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sep 30, 2026 | 2.35 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 2.38 | — | — | — |
| May 13, 2026 | Mar 31, 2026 | 2.25 | 2.44 | +0.19 | +8.44% |
| Mar 5, 2026 | Dec 31, 2025 | 2.29 | 2.21 | -0.08 | -3.49% |
| Nov 12, 2025 | Sep 30, 2025 | 2.59 | 2.42 | -0.17 | -6.56% |
| Aug 7, 2025 | Jun 30, 2025 | 2.52 | 1.77 | -0.75 | -29.76% |
News
Why Is Silence Therapeutics Stock Skyrocketing Monday? 
Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal 
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover 
Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday 
Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal 
Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…' 
Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges 
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times 
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? 
Stocks That Hit 52-Week Highs On Tuesday
Your note
Sign in to keep a note on MKGAF — it syncs with the Stock Master app.